Instant Diagnostic Systems (IDS), an Independent Diagnostic Testing Facility (IDTF) that specializes in home-based diagnostic testing, has earned The Joint Commission’s Gold Seal of Approval for accreditation. The accreditation award recognizes IDS’s dedication to continuous compliance with The Joint Commission’s standards in ambulatory health, telehealth, and sleep studies.
Mark Sorrells, president and CEO of IDS, said, ”Although accreditation is not a requirement for our type of health care facility in most jurisdictions, IDS felt it was important to pursue accreditation through The Joint Commission to demonstrate our commitment to providing high-quality health care to patients nationwide.”
Since 1975, The Joint Commission has developed standards for outpatient ambulatory care organizations. These standards address important functions relating to the care of patients and the management of an ambulatory care organization; and are developed in consultation with health care experts, providers, measurement experts, and patients.
“As the largest provider of overnight oximetry and home sleep testing in the United States, we hold ourselves accountable to a higher standard to provide high-quality, cost-effective diagnostic tests that patients can self-administer in their own homes,” Sorrells said. “With as many as 20 million Americans currently undiagnosed with sleep apnea, the number of home sleep tests performed by IDS is growing rapidly. Primary care physicians realize they can order a home sleep test and provide treatment to many of their patients without the patient going to an in-lab facility for the test at a significantly greater cost.“